Characteristics of Patients With Overactive Bladder Who Escalate to a Higher Dose of Antimuscarinic: Efficacy and Safety Outcomes

Goldman H1, Oelke M2, Kaplan S A3, Kitta T4, Russell D5, Carlsson M5, Arumi D6, Mangan E5, Ntanios F5

Research Type


Abstract Category

Overactive Bladder

Abstract 118
Open Discussion ePoster
Scientific Open Discussion Session 8
Wednesday 7th October 2015
12:40 - 12:50 (ePoster Station 11)
E-Poster Area (210ABEF)
Clinical Trial Incontinence Urgency Urinary Incontinence
1. The Cleveland Clinic, 2. Hannover Medical School, 3. Weill Cornell Medical College, 4. Hokkaido University, 5. Pfizer Inc, 6. Pfizer Europe

Fady Ntanios



25/07/2021 04:32:15